This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Entain | 569.8 | 2.6% |
| Intertek Group | 5,570.0 | 2.1% |
| BT Group | 204.5 | 1.5% |
| British American Tobacco | 4,469.0 | 1.5% |
| Vodafone Group | 111.9 | 1.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Scottish Mortgage Investment Trust | 1,438.0 | -2.8% |
| Berkeley Group Holdings | 3,392.0 | -2.8% |
| Persimmon | 1,041.5 | -2.5% |
| Barratt Redrow | 253.4 | -2.4% |
| Lion Finance Group | 10,340.0 | -2.0% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 10,373 | 0.1% | 17.4% |
| DOW JONES INDUS. AVG | 50,786 | 0.2% | 18.8% |
| DAX INDEX | 24,616 | 0.6% | 1.8% |
| NIKKEI 225 | 65,387 | 2.1% | 71.7% |
| S&P/ASX 200 INDEX | 8,604 | 0.2% | 1.0% |
| Commodity | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 90.08 | 1.34% |
| Brent Crude (ICE) | USD/bbl. | 93.28 | 1.03% |
| Gold Spot | USD/t oz. | 4,338 | 0.2% |
| Copper (Comex) | USd/lb. | 636 | 0.2% |
Click graph to enlarge
The UK 100 is called to open -5 points at at 10,368. The UK 100 looks set to open broadly flat, down less than three points, after yesterday the UK benchmark extended its winning run to a third day, though with a gain of only five points to 10,373.20.
Overnight, Wall Street stocks clawed back some ground from big losses on Friday, powered by the tech sector as the Nasdaq climbed 0.9%, the S&P 500 gained 0.3%, but the Dow Jones slipped 0.2%.
Brent crude oil is down 1.3% to just over $93 a barrel this morning, while Asian stocks are mostly higher, led by Korea’s KOSPI and Japan’s Nikkei, up 7.6% and 2% respectively. Chinese and Hong Kong benchmarks are just above flat.
Bellway said on Tuesday customer demand has cooled after a positive start to the spring selling season, with rising building costs from higher fuel and energy prices adding to challenges in the housing sector. The update comes after Bellway’s profit margin warning in March, mirroring moves by rivals such as Taylor Wimpey, as the sector grapples with mounting energy and input costs stemming from the Iran war, while demand softens as mortgage rates climb. “The outlook beyond the current financial year remains uncertain, reflecting ongoing geopolitical tensions in the Middle East and a less predictable domestic political environment,” CEO Jason Honeyman said in a statement. The company maintained its underlying operating profit forecast of £320 million-£330 million ($427.65 million-$441.01 million) and volume output target of 9,300-9,500 homes for the year ending July 2026, despite the challenging conditions.
GSK‘s new CEO Luke Miels has not wasted any time in setting out his stall as a dealmaker, with a deal struck to snap up US biotechnology company Nuvalent for £8 billion ($10.6 billion), adding “immediate” new sales growth opportunities, as well as a trio of advanced lung cancer drugs and other assets to boost its oncology pipeline.
UK
Bellway (BWY) – Trading Update
US
GameStop (GME) AMC E
UK
Pennon Group (PNN) – Full Year Results 2025/26
Workspace Group (WKP) – Full Year Results
US
Oracle (ORCL) AMC E
UK BRC Like-For-Like Retail Sales
US ADP Employment Change 4-week average
US Existing Home Sales Change
UK 100 companies going ex-dividend on 4th June 2026:
ICG
Scottish Mortgage Investment Trust
UK 250 companies going ex-dividend on 11th June 2026:
C&C Group
B&M European Value Retail
RS Group
3i Infrastructure
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.